Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JenaValve
MedTech
FTC aims to stop Edwards’ acquisition of JenaValve
The FTC moved to block Edwards Lifesciences’ buyout of JenaValve and its heart implant for aortic regurgitation, slated for FDA approval this year.
Conor Hale
Aug 7, 2025 11:33am
Edwards inks $1.6B in deals for JenaValve, Endotronix
Jul 25, 2024 11:00am
JenaValve nabs $100M to clear TAVR system’s FDA pathway
Aug 31, 2022 3:35pm
TAVR developer JenaValve nets $50M from Bain Capital
Feb 7, 2020 10:25am
